trending Market Intelligence /marketintelligence/en/news-insights/trending/been-nfk2dhadzamn7vrla2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Halozyme Therapeutics director to step down

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Halozyme Therapeutics director to step down

Randal Kirk informed Halozyme Therapeutics Inc. of his unavailability to serve as a director due to his growing commitments outside of the company.

Due to this development, Kirk will not be nominated for re-election to the board at the upcoming stockholders' annual meeting.

San Diego, Calif.-based Halozyme Therapeutics is a biotechnology company which researches, develops, and commercializes human enzymes and other drug candidates in the U.S., Switzerland, and internationally.